Platform Technology Partners Sells 97 Shares of Stryker Co. (NYSE:SYK)

Platform Technology Partners trimmed its position in shares of Stryker Co. (NYSE:SYKFree Report) by 10.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 807 shares of the medical technology company’s stock after selling 97 shares during the period. Platform Technology Partners’ holdings in Stryker were worth $242,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. NewEdge Wealth LLC lifted its holdings in shares of Stryker by 2.5% during the third quarter. NewEdge Wealth LLC now owns 2,011 shares of the medical technology company’s stock valued at $550,000 after purchasing an additional 50 shares during the last quarter. Atria Wealth Solutions Inc. lifted its holdings in shares of Stryker by 1.1% during the third quarter. Atria Wealth Solutions Inc. now owns 17,364 shares of the medical technology company’s stock valued at $4,751,000 after purchasing an additional 183 shares during the last quarter. Blueshift Asset Management LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $240,000. Sequoia Financial Advisors LLC lifted its holdings in shares of Stryker by 1.0% during the third quarter. Sequoia Financial Advisors LLC now owns 4,585 shares of the medical technology company’s stock valued at $1,253,000 after purchasing an additional 44 shares during the last quarter. Finally, Burney Co. lifted its holdings in shares of Stryker by 47.9% during the third quarter. Burney Co. now owns 1,210 shares of the medical technology company’s stock valued at $331,000 after purchasing an additional 392 shares during the last quarter. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on SYK. Stifel Nicolaus boosted their price objective on shares of Stryker from $350.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Wells Fargo & Company boosted their price objective on shares of Stryker from $364.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 1st. The Goldman Sachs Group began coverage on shares of Stryker in a report on Thursday, May 30th. They issued a “neutral” rating and a $372.00 price objective for the company. Piper Sandler boosted their price objective on shares of Stryker from $375.00 to $380.00 and gave the stock an “overweight” rating in a report on Wednesday, May 1st. Finally, Robert W. Baird boosted their price objective on shares of Stryker from $367.00 to $378.00 and gave the stock an “outperform” rating in a report on Wednesday, May 1st. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $370.58.

View Our Latest Stock Analysis on SYK

Stryker Stock Performance

Shares of SYK stock traded down $0.30 during mid-day trading on Friday, reaching $349.33. 847,236 shares of the company’s stock traded hands, compared to its average volume of 1,371,109. Stryker Co. has a 12 month low of $249.98 and a 12 month high of $361.41. The firm has a 50 day moving average price of $337.38 and a two-hundred day moving average price of $328.08. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The firm has a market capitalization of $133.08 billion, a PE ratio of 39.88, a price-to-earnings-growth ratio of 2.75 and a beta of 0.92.

Stryker (NYSE:SYKGet Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. The firm had revenue of $5.24 billion during the quarter, compared to the consensus estimate of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.14 EPS. On average, research analysts forecast that Stryker Co. will post 11.95 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Friday, June 28th. Stryker’s dividend payout ratio is currently 36.53%.

About Stryker

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Read More

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYKFree Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.